Pennsylvania HB 137: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Status: Referred to JUDICIARY (as of 2019-12-26)

State: Pennsylvania · Session: 2019-2020 · Bill: HB 137

Sponsors: Quinn, Barrar, Conklin, Cox, Everett, Hahn, Hill-Evans, Johnson-Harrell, Kortz, Mcneill, Rothman, Saylor, Simmons, Staats, Struzzi

View Pennsylvania HB 137 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.